Google open-sourced Harness2, a recursive agent harnessing framework that lifted GLM-5 11.5 points on WorkBuddy-Bench with ...
Gilead Sciences (GILD) will present HIV and antiviral research at IDWeek 2026, taking place October 21–24 in Washington, D.C. – Analyses of Bixlenvo™ (bictegravir 75 mg/lenacapavir 50 mg) Examine ...
A comprehensive look at the safety data from the MARIPOSA-2 trial, including rates of adverse events, toxicities, and treatment modifications across the three regimens. Specific details are provided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results